+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a novel Bayesian method for individualizing theophylline dosage

Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 26(6): 405-414

Evaluation of a novel Bayesian method for individualizing theophylline dosage

A novel Bayesian drug dosing program (Abbott Pharmacokinetic Systems, Theophylline Program) was evaluated. The predictive accuracy of this method was assessed in 10 healthy volunteers receiving single intravenous test doses. Estimates for clearance and distribution volume were compared with those obtained from the area under the curve. The observed prediction error depended largely on sampling time. The deviations were lowest for the distribution volume during the first 60 min and for clearance at 12 hours after theophylline administration. Furthermore the Bayesian technique was prospectively evaluated in 10 hospitalized and 22 outpatients treated with sustained-release theophylline preparations (Uniphyllin, Bronchoretard, PulmiDur). Predictive precision and accuracy were adequate, if theophylline was givne twice daily. The highest predictive accuracy was achieved in outpatients, if predictions were based on trough concentrations. In 19/22 outpatients prediction errors were given a clinically acceptable range (mean prediction error .+-. standard deviation; -0.6 .+-. 2.1 mg/l). Moreover in hospitalized patients (n = 5) with twice-daily maintenance regimens, concerntration-time curves could mainly be predicted with sufficient accuracy. Hospitalized patients (n = 5) with once-daily dosing showed large fluctuations between peak and trough theophylline concentrations in serum. In these patients a reliable prediction of the concentration-time curves was not possible apparently due to non-linearity of theophylline kinetics. Relatively large prediction errors were found in one patient with acute viral respiratory illness ad 3 patients with altered absorption. Despite certain limitations the clinical application of the Bayesian forecasting method tested appears to be promising.

(PDF same-day service: $19.90)

Accession: 005395469

PMID: 3411295

DOI: 10.1515/cclm.1988.26.6.405

Related references

Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method. European Journal of Clinical Pharmacology 26(4): 491-498, 1984

Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing. Therapeutic Drug Monitoring 13(5): 420-424, 1991

Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation. Journal of Clinical Pharmacology 49(7): 789-797, 2009

A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage. Clinical Pharmacokinetics 14(5): 311-320, 1988

Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models. Therapeutic Drug Monitoring 11(4): 450-454, 1989

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Therapeutic Drug Monitoring 15(5): 380-393, 1993

Evaluation of a bayesian method for the estimation of pharmacokinetic parameters of theophylline in pediatric patients. Farmacia Clinica 6(5): 317-332, 1989

Evaluation of a single point method for predicting theophylline dosage. Clinical Pharmacy 1(5): 441-446, 1982

The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline. Arerugi 43(4): 563-570, 1994

Rational phenytoin therapy: a method for individualizing dosage. Zhonghua Yi Xue Za Zhi 66(3): 134-6, 188, 1986